Related Experiment Video
Updated: Feb 26, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy
Marzia De Bortoli1, Chiara Calore2, Alessandra Lorenzon1
1Department of Biology, University of Padua, Padua, Italy.
Insights
Co-inheritance of arrhythmogenic cardiomyopathy (ACM) and hypertrophic cardiomyopathy (HCM) gene mutations was observed in two families. Double heterozygotes showed variable clinical expression, not a more severe phenotype than single mutation carriers.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Basis of Cardiomyopathies
Background:
- Arrhythmogenic cardiomyopathy (ACM) and hypertrophic cardiomyopathy (HCM) are distinct genetic myocardial disorders.
- Genetic mutations are known causes for ACM and HCM individually.
- The implications of co-inheriting mutations for both conditions are not well understood.
Purpose of the Study:
- To investigate the co-inheritance of ACM and HCM-associated gene mutations in families with recurrent cardiomyopathies.
- To analyze the clinical presentation and phenotype of individuals with double heterozygous mutations.
Main Methods:
- Genetic analysis of two families with recurrent ACM and HCM.
- Identification of mutations in genes such as DSP, MYBPC3, CTTNA3, and MYH7.
- Clinical phenotyping and assessment against diagnostic criteria for ACM and HCM.
Main Results:
- Co-inheritance of DSP and MYBPC3 mutations in Family A, with affected individuals diagnosed with either ACM or HCM.
- Identification of CTTNA3 and MYH7 mutations in Family B, with one patient not meeting criteria for either cardiomyopathy.
- Variable clinical expression observed in double heterozygotes, without a consistently more severe phenotype compared to single mutation carriers.
Conclusions:
- This study presents the first evidence of co-inheritance of ACM and HCM-associated mutations.
- Double heterozygosity can lead to variable presentations, including diagnoses of ACM or HCM, or phenotypes not meeting current criteria.
- The clinical impact of co-inheriting these specific mutations requires further investigation, as severity is not uniformly increased.
Abstract:
Arrhythmogenic cardiomyopathy (ACM) and hypertrophic cardiomyopathy (HCM) are genetically and phenotypically distinct disorders of the myocardium. Here we describe for the first time co-inheritance of mutations in genes associated with ACM or HCM in two families with recurrence of both cardiomyopathies. Among the double heterozygotes for mutations in desmoplakin (DSP) and myosin binding protein C (MYBPC3) genes identified in Family A, two were diagnosed with ACM and two with HCM. In Family B, one patient was identified to carry mutations in α-T-catenin (CTTNA3) and β-myosin (MYH7) genes, but he does not fulfill the current diagnostic criteria neither for ACM nor for HCM. Interestingly, the double heterozygotes showed a variable clinical expression of both cardiomyopathies and they do not exhibit a more severe phenotype than family members carrying only one of the two mutations.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Cardiomyopathy V: Interprofessional Care

